The Medications That Lower Desire, Named
This is the first thing worth checking and the last thing most people check. A medication cause is common, it is often reversible, and establishing it costs nothing but a conversation. It is missed for a dull, structural reason: the side effect is rarely raised when the prescription is written, so years later nobody connects a symptom that arrived in one season to a tablet that started in the same one.
The whole of the useful advice on this page depends on one rule, so it comes first. Do not stop or change anything on your own. Nothing below is a reason to discontinue a medication. The reason it was prescribed has not gone away, several of these are dangerous to stop abruptly, and the productive move is to take the question to whoever prescribed it.
The timeline test, which costs nothing
Before any list, the single most useful piece of evidence: date the change, then date the prescriptions.
Write down the month desire changed — not the year, the month, as closely as you can place it. Then set it against every medication started, stopped or changed in the surrounding season, including ones taken intermittently and ones bought over the counter. If the two line up within a few weeks of each other, that is a stronger signal than any blood test will produce, and it is the finding that most often ends this investigation.
Two honest complications. First, illness confounds it: an antidepressant started for depression arrives at a moment when depression itself is flattening desire, so the question is not whether desire was low at the start but whether it stayed low after mood improved. Second, some effects are not immediate, and a gradual onset over a few months does not rule a drug out.
The classes worth naming
Antidepressants — SSRIs and SNRIs. The most common medication cause we see, in both sexes. The effects are reduced desire, delayed or absent orgasm, and reduced genital sensation, and they are common rather than rare. They are also dose-related and agent-related: the profile is not uniform across the class, and some agents are substantially less associated with it than others, which is exactly why this is a productive conversation with a prescriber. Options a prescriber may weigh include changing agent, adjusting how a drug is taken, or adding something — none of which is a decision to make from a web page, and none of which should involve stopping abruptly, because discontinuation symptoms and relapse are both real risks.
Finasteride and dutasteride. Taken for hair loss or for prostate symptoms, and associated in a minority of men with reduced desire and erectile difficulty. Reports of symptoms persisting after stopping exist and are contested; the honest position is that the frequency is disputed and the mechanism is not settled, and that a man for whom this matters should be told about it before he starts rather than after. We cover it in detail in finasteride and sexual side effects.
Blood pressure medications. Not the whole category. Older beta-blockers and thiazide diuretics are the ones most associated with reduced desire and erectile difficulty; ACE inhibitors, angiotensin receptor blockers and calcium channel blockers are generally less so. Because there are several classes that do the same job, this is one of the more changeable items on the list. It is also the one where stopping on your own does the most harm: untreated high blood pressure damages the vascular function that arousal depends on, so quitting the tablet makes the sexual problem worse by the longer route.
Hormonal contraception. Still relevant in this age group — plenty of women in their forties are on it for contraception, for heavy or erratic perimenopausal bleeding, or for both. Combined hormonal contraception raises sex hormone binding globulin, which lowers the fraction of testosterone available to tissue, and some women report reduced desire on it. The trial evidence is genuinely mixed rather than conclusive, and most women notice nothing. What is not acceptable is the reflex of telling a woman who did notice that it cannot be the pill.
Opioids. These suppress the hypothalamic-pituitary-gonadal axis directly, which lowers testosterone in men and in women. The effect is well described and has a name in the literature. Anyone on long-term opioid therapy who reports low desire, fatigue and low mood is describing a recognized consequence of the treatment, not a coincidence.
The rest of the list, in brief. Antipsychotics that raise prolactin. Some antiepileptics. Spironolactone, which is anti-androgenic. Older H2 blockers. Anti-androgen therapy for prostate cancer, where the effect is the intended mechanism rather than a side effect. And alcohol, which is not prescribed but behaves exactly like a drug on this list — reducing both desire and function at volumes most people would not describe as heavy and would not think to mention.
What to ask the person who prescribed it
Three questions, in this order, and they work better written down than remembered.
Is this drug a plausible cause of the change I am describing? A prescriber can answer that in a sentence, and the answer is frequently yes.
Is there an alternative that does the same job with a different profile? For antihypertensives and antidepressants there very often is. For some drugs there is not, and that is worth knowing too.
If we change something, how will we tell whether it worked? Agree in advance on what you are watching and over what period, because desire is slow to move and memory is unreliable. A decision made without that step tends to become a permanent uncertainty.
If the answer is that the medication is necessary and there is no good alternative, that is a real answer, not a failure. It changes the question from removing a cause to working around one — and it tells you where the rest of the effort should go.
Frequently asked questions
Yes, commonly, in both sexes — reduced desire, delayed or absent orgasm, and reduced sensation. The profile differs between agents, which is why it is worth raising with the prescriber rather than accepting as the price of treatment.
No. Do not stop or reduce it on your own. Stopping abruptly risks discontinuation symptoms and relapse, and the depression that reduced desire in the first place is worse for it than the medication is. Take the side effect to the prescriber as a problem to be solved.
It could, particularly an older beta-blocker or a thiazide diuretic. There are other classes that do the same job, so this is often changeable — but untreated high blood pressure harms sexual function by damaging blood vessels, so the change is made with the prescriber, not instead of them.
A minority of men report reduced desire and erectile difficulty on it, and reports of persistence after stopping exist and are disputed. The frequency is not settled. It is a conversation to have before starting.
It can. Combined hormonal contraception raises sex hormone binding globulin, which reduces the testosterone available to tissue, and some women notice a difference. The evidence across trials is mixed, and most women do not — but your own observation is data, and it should not be waved away.
Then it was probably not the whole answer, which is useful information rather than a dead end. Desire is rarely one thing, and the next places to look are sleep, mood, alcohol, hormones and context — see when low desire is worth testing.
Where this fits in your plan
Bring the complete list to the assessment. Complete means prescriptions, over-the-counter medicines, supplements, anything taken only sometimes, and anything stopped in the past year. Add the month your desire changed. That pairing is the most useful single thing anyone supplies in this consultation.
What we can do with it is read it against a proper history and a panel, and say plainly where we think a medication is the likely driver. What we cannot do is change a prescription written by someone else, and we will not tell you to stop one. Where the answer is a conversation with your own prescriber, that is what we will say — see our safety and medication FAQ for how we handle medication from other clinicians.
We measure first. Then we act.
References
- FDA prescribing information for selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors — Adverse Reactions (sexual dysfunction); Warnings and Precautions (discontinuation).
- FDA prescribing information for finasteride — Adverse Reactions, including reports of sexual adverse events and of persistence after discontinuation.
- American Heart Association / American College of Cardiology. Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults.
- American College of Obstetricians and Gynecologists. Combined Hormonal Contraception — ACOG Practice Bulletin.
- Endocrine Society. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline — opioid-associated androgen deficiency.
- National Institute of Diabetes and Digestive and Kidney Diseases (NIH). Symptoms and Causes of Erectile Dysfunction — medications as a contributing cause.
- Back toLow Libido
- Desire is not arousalDesire, arousal and function are separate systems with separate causes. Which one changed decides what is worth treating — and what will not.Read
- Responsive vs spontaneous desireMany people never feel desire out of nowhere — it arrives after arousal. That is a pattern, not a deficiency, and it changes what is worth treating.Read
- When testing is worth itA panel earns its place when a plausible result changes the plan. Where testing genuinely settles low desire, where it does not, and what a normal result means.Read
- When the cause is not in the bloodSleep debt, chronic stress, a changed body, past pain and relationship context all suppress desire and none of them show on a blood test. Taken seriously.Read
- Causes worth ruling out firstLow desire in midlife is rarely one thing, and testosterone is rarely the whole answer. The causes worth checking, in the order they usually turn out to matter.Read
- Lab testingComprehensive blood, hormone, gut, methylation and glucose testing — the baseline every plan is built on.Read
How we write and review our content
ACT 2 Health provides clinician-led care. Treatments are available only to eligible patients following clinical evaluation and within applicable regulations. This content is educational and is not medical advice. Individual results vary.
Care is delivered via telemedicine by healthcare professionals licensed in the state where the patient is located. Services are available only in states where our providers are licensed.
Do not stop, reduce or change any prescribed medication on the strength of this page. Discuss it with the clinician who prescribed it — stopping some medications abruptly, including antidepressants and blood pressure medication, carries real risk.